Medicare and Medicaid Expand Coverage to Include Weight-Loss Drugs for Patients at Risk of Heart Disease
In a significant move to address the rising rates of obesity and related health issues, Medicare and Medicaid have expanded coverage to include weight-loss drugs like Wegovy for patients at risk of heart disease. This decision is expected to benefit patients who are in need of weight-loss treatment but may have struggled to access it due to financial constraints.
NPR’s Scott Simon recently spoke with Dr. Disha Narang of Endeavor Health in Illinois to discuss the benefits of Wegovy and other weight-loss drugs now covered by Medicare and Medicaid. Dr. Narang emphasized the importance of insurance coverage for medications like Wegovy in helping patients manage their weight and reduce their risk of heart disease.
The inclusion of weight-loss drugs like Wegovy in Medicare and Medicaid coverage reflects a growing recognition of obesity as a serious health concern that requires medical intervention. With obesity being a major risk factor for heart disease, providing access to prescription weight-loss medications through these insurance programs is a crucial step in improving the overall health and well-being of patients.
Patients who are at risk of heart disease and struggle with obesity can now access prescription weight-loss medications like Wegovy through their Medicare or Medicaid coverage. This proactive approach to addressing weight-related health issues highlights the importance of preventive care and showcases a commitment to helping patients lead healthier lives.
“Zombie enthusiast. Subtly charming travel practitioner. Webaholic. Internet expert.”